Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse-Reference-Cited by-同舟云学术

Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse

Published:2016-12-14 Issue:3 Volume:33 Page:519-527
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Irish William¹,Ryan Michael¹,Gache Larry¹,Gunnarsson Candace¹,Bell Timothy²,Shapiro Mark²

Affiliation:

1. CTI Clinical Trial and Consulting Services Inc., Cincinnati, OH, USA;

2. Pfizer Inc, New York, NY, USA

Funder

Pfizer Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1267615

Reference29 articles.

1. American Cancer Society. Acute Myeloid Leukemia. Available at: http://www.cancer.org/cancer/leukemia-acutemyeloidaml/index [Last accessed 7 December 2016]

2. Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

3. Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

4. Surveillance, Epidemiology, and End Results (SEER). National Cancer Institute. SEER Stat Fact Sheets: Acute Myeloid Leukemia. Available at: http://seer.cancer.gov/statfacts/html/amyl.html [Last accessed 7 December 2016]

5. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Version 2.2016, Available at: https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf [Last accessed 7 December 2016]

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study;Advances in Therapy;2024-09-06

2. Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database;Leukemia Research;2023-09

3. Financial toxicity in patients with leukemia undergoing hematopoietic stem cell transplantation: A systematic review;Best Practice & Research Clinical Haematology;2023-06

4. In Silico Post Translational Analysis of Functional Single Nucleotide Alterations in Human TERT Gene Associated with Acute Myeloid Leukemia;Pakistan BioMedical Journal;2023-05-31

5. Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial;BMC Cancer;2022-11-14